Addressing challenges to rolling out COVID-19 vaccines in African countries

Jean B Nachega¹, Nadia A Sam-Agudu², Refiloe Masekela³, Marieke M van der Zalm⁴, Sabin Nsanzimana⁵, Jeanine Condo⁶, Francine Ntoumi⁷, Helena Rabie⁴, Mariana Kruger⁴, Charles S Wiysonge⁸, John D Ditekemena⁹, Raphael B Chirimwami¹⁰, Mukanire Ntakwinja¹¹, Denis M Mukwege¹¹, Emilia Noormahomed¹², Masudah Paleker¹³, Hassan Mahomed¹³, Jean-Jacques Muyembe Tamfum¹⁴, Alimuddin Zumla¹⁵, Fatima Suleman¹⁶

Affiliations

¹ Department of Medicine and Center for Infectious Diseases, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Epidemiology, Infectious Diseases and Microbiology, Center for Global Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jnachega@sun.ac.za.
² International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria; Department of Pediatrics and Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, USA; Department of Pediatrics and Child Health, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
³ Department of Paediatrics and Child Health, School of Clinical Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
⁴ Department of Pediatrics and Child Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
⁵ Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
⁶ School of Public Health, University of Rwanda, Kigali, Rwanda; School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
⁷ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
⁸ Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
⁹ School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo.
¹⁰ Université Catholique de Bukavu, Centre d'Ethique Medicale, Bukavu, DR Congo.
¹¹ Panzi Hospital, Université Evangelique en Afrique, Bukavu, DR Congo.
¹² Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
¹³ Division of Health Systems and Public Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Western Cape Department of Health, Cape Town, South Africa.
¹⁴ Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo; National Institute of Biomedical Research, Kinshasa, DR Congo.
¹⁵ Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK.
¹⁶ Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.

PMID: 33713633
PMCID: PMC7946417
DOI: 10.1016/S2214-109X(21)00097-8

Addressing challenges to rolling out COVID-19 vaccines in African countries

Jean B Nachega et al. Lancet Glob Health. 2021 Jun.

. 2021 Jun;9(6):e746-e748.

doi: 10.1016/S2214-109X(21)00097-8. Epub 2021 Mar 10.

Authors

Affiliations

¹ Department of Medicine and Center for Infectious Diseases, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Department of Epidemiology, Infectious Diseases and Microbiology, Center for Global Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jnachega@sun.ac.za.
² International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja, Nigeria; Department of Pediatrics and Institute of Human Virology, School of Medicine, University of Maryland, Baltimore, MD, USA; Department of Pediatrics and Child Health, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.
³ Department of Paediatrics and Child Health, School of Clinical Medicine, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.
⁴ Department of Pediatrics and Child Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
⁵ Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
⁶ School of Public Health, University of Rwanda, Kigali, Rwanda; School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA, USA.
⁷ Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of the Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
⁸ Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa.
⁹ School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo.
¹⁰ Université Catholique de Bukavu, Centre d'Ethique Medicale, Bukavu, DR Congo.
¹¹ Panzi Hospital, Université Evangelique en Afrique, Bukavu, DR Congo.
¹² Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.
¹³ Division of Health Systems and Public Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; Western Cape Department of Health, Cape Town, South Africa.
¹⁴ Department of Medical Microbiology and Virology, Faculty of Medicine, University of Kinshasa, Kinshasa, DR Congo; National Institute of Biomedical Research, Kinshasa, DR Congo.
¹⁵ Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals, London, UK.
¹⁶ Discipline of Pharmaceutical Sciences, School of Health Sciences, College of Health Sciences, University of KwaZulu Natal, Durban, South Africa.

PMID: 33713633
PMCID: PMC7946417
DOI: 10.1016/S2214-109X(21)00097-8

No abstract available

PubMed Disclaimer

References

1. WHO COVID-19 vaccines. 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19...
1. Africa Centres for Disease Control and Prevention Framework for fair, equitable and timely allocation of COVID-19 vaccines in Africa. Jan 31, 2021. https://africacdc.org/download/framework-for-fair-equitable-and-timely-a...
1. Hoen E. How the world can put sharing above profits in the race for a vaccine. April 16, 2020. https://www.barrons.com/articles/a-vaccine-for-all-not-if-these-companie...
1. Latkin CA, Dayton L, Yi G, Colon B, Kong X. Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US. PLoS One. 2021;16 - PMC - PubMed
1. Dinga JN, Sinda LK, Titanji VPK. Assessment of vaccine hesitancy to a COVID-19 vaccine in Cameroonian adults and its global implication. Vaccines. 2021;9:175. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Addressing challenges to rolling out COVID-19 vaccines in African countries

Affiliations

Addressing challenges to rolling out COVID-19 vaccines in African countries

Authors

Affiliations

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical